Sign In
Buy HUGE
$0.0899
+0 (+0%)
At Close: Nov 15, 2024
FSD Pharma Begins Phase 1 In-human Safety and Tolerability Study of Ultra Micro-Palmitolylethanolamide (PEA)
12:30pm, Monday, 09'th Mar 2020
The study is now underway at Alfred Hospital in Melbourne and is being led by principal researcher Jason Lickliter , MD, Chief Medical Officer of Nucleus Network, Australia's largest and most ex
FSD Pharma Inc., Worldwide License of Natural Fatty Acid, CEO Clip Video
06:14pm, Friday, 06'th Mar 2020
Vancouver, British Columbia--(Newsfile Corp. - March 6, 2020) - FSD Pharma Inc. (CSE: HUGE) (NASDAQ: HUGE) CEO and Executive Co-Chairman, Dr. Raza Bokhari speaks about the company's worldwide licens
FSD Pharma to Ring the Opening Bell of the Canadian Securities Exchange On Friday, March 6, 2020
07:30am, Wednesday, 04'th Mar 2020
FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company") today announced that Executive Co-Chairman and CEO, Raza Bokhari, MD will be joined by the Company’s founders,
Vancouver, British Columbia--(Newsfile Corp. - February 24, 2020) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A), a specialty, biotech pharmaceutical R&D; company focused on developing, over
FSD Pharma Sells Cannara Biotech Stake, Netting More Than $7.7M
05:20pm, Friday, 21'st Feb 2020
FSD Pharma Inc (NASDAQ: HUGE) has netted itself more than $7.7 million through the sale of its 12% equity interest in Cannara Biotech Inc (OTC: LOVFF) to a consortium of that included entities control
The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study
12:06pm, Thursday, 20'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Akebia
FSD Pharma Generates $7.7 Million in Proceeds and 670% Return on Investment through Sale of Interest in Cannara Biotech
07:30am, Thursday, 20'th Feb 2020
The terms of the Share Sale Transaction were negotiated at arm's length with a group of buyers that included entities controlled by members of the Cannara board and senior management. A substantial p
FSD Pharma CEO, Dr. Raza Bokhari, Discusses 2020 Goals with The Stock Day Podcast
02:30pm, Tuesday, 11'th Feb 2020
Phoenix, Arizona--(Newsfile Corp. - February 11, 2020) - The Stock Day Podcast welcomed FSD Pharma (NASDAQ: HUGE) (the Company"), a specialty biotech pharmaceutical R&D; company focused on developing
FSD Pharma Chairman & CEO to Present at 22nd Annual BIO CEO & Investor Conference in NYC
07:30am, Wednesday, 05'th Feb 2020
FSD Pharma Chairman & CEO to Present at 22nd Annual BIO CEO & Investor Conference in NYC
FSD Pharma and Solarvest Enhance Commitment to CBD Research Project
07:30am, Tuesday, 04'th Feb 2020
FSD Pharma and Solarvest Enhance Commitment to CBD Research Project
Seasoned Healthcare Executive and Academic Luminary Larry Kaiser, MD, Joins FSD Pharma Board of Directors
07:30am, Wednesday, 22'nd Jan 2020
TORONTO , Jan. 22, 2020 /CNW/ - FSD Pharma Inc. (HUGE) (HUGE.CN) (FRA: 0K9A) ("FSD Pharma" or the "Company") today announced that it has appointed Larry Kaiser , MD, FACS to its Board of Dire
